The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org.
The Laboratory Services Team (LST) is a key source of support for Ministries of Health and CHAI's country teams, and works to address barriers to access and foster a healthy competitive marketplace for essential diagnostic testing. LST plays the lead role in coordinating work globally on access to diagnostics, working closely with diagnostics manufacturers, governments, and multilateral organizations to lower prices, increase access to testing, and accelerate the entry and uptake of new innovative products.
Historically, the majority of diagnostic testing for HIV and TB has been conducted on conventional, laboratory-based technologies using sample transportation systems to expand access to testing to patients living in rural areas. However, access to these products is limited in many countries, and Ministries of Health require continued support to improve the efficiency of these technologies, expand their reach, and introduce new types of essential tests. In addition, several POC products for diagnosis, disease staging, and treatment monitoring have recently become available or are in development, with the potential to dramatically increase access to treatment, improve patient retention, and make healthcare systems more efficient. These technologies need to be integrated with existing conventional laboratory networks, with an appropriate balance between centralized and decentralized testing.
The Strategy & Country Support Manager (SCSM) will work with the Laboratory Services Team (LST) to ensure the rapid scale-up and effective management of high-quality diagnostics for high burden diseases, focusing primarily on diagnostics for patients with HIV or TB. The SCSM will work with Ministries of Health and CHAI country teams across multiple focal countries, helping to optimize policies and processes, expand access to high quality diagnostics, ensure that countries have adopted best practices in planning and implementation of testing programs, and support forecasting and procurement of essential diagnostic products.
The SCSM will support countries in the implementation of both conventional, laboratory-based diagnostic products and new, innovative POC products that bring diagnostics out of the laboratory and closer to the patient. In particular, The SCSM will support countries in adopting the most recent WHO guidelines for HIV and TB care and achieve the global targets agreed upon across CHAI countries and major partners. For example, on HIV, this includes reaching the UNAIDS 90-90-90 targets by 2020 by working with countries to develop and implement innovative strategies for scaling up testing and monitoring programs, which include HIV diagnosis (targeting key populations in lower prevalence settings), CD4 testing, Early Infant Diagnosis (EID) and viral load (VL) monitoring of patients on anti-retroviral therapy (ART). In addition, the SCSM will assist countries with the evaluation, adoption and uptake of new POC diagnostic products, which can reduce the burden of undergoing testing, and improve access to essential tests, particularly in rural areas.
The SCSM will also support LST in global negotiations with diagnostics manufacturers to lower prices, and with the development of new procurement strategies such as instrument rental deals to enable easier product switching. Finally, the SCSM will help develop LST's market-shaping strategy for fostering competition in the global diagnostics market. In doing so, the SCSM will develop strong relationships with various teams within CHAI, as well as Ministries of Health, diagnostics manufacturers, and other external partners in beneficiary countries.
We are seeking a highly motivated individual with outstanding credentials, qualitative and quantitative analytical abilities, and communication skills. The SCSM must be able to function independently and flexibly and have a strong commitment to excellence. CHAI places great value on relevant personal qualities: resourcefulness, responsibility, tenacity, independence, energy, work ethic and emotional intelligence.
This is a challenging but rewarding role, which will have direct and near-term impact on thousands of patients in need of life-saving health services. The role will be based in a CHAI Program Country in sub-Saharan Africa with up to 50% travel time.